Literature DB >> 15735705

Phosphorylation of MdmX by CDK2/Cdc2(p34) is required for nuclear export of Mdm2.

Bertha Elias1, Aaron Laine, Ze'ev Ronai.   

Abstract

Mdm2 and MdmX function as cellular regulators of the p53 tumor suppressor protein. Intriguingly, the activities of these proteins are interdependent; MdmX stabilizes Mdm2, enabling its activities towards p53, but it also requires Mdm2 for its nuclear localization. Here we demonstrate that via its phosphorylation by CDK2/Cdc2p34, MdmX regulates nuclear export of Mdm2. Cdc2p34 phosphorylates MdmX on Ser 96 in vitro. Mutation within this site (MdmX(S96A)) impairs, whereas phosphomimic substitution (MdmX(S96D)) increases the cytoplasmic localization of MdmX, suggesting that CDK2/Cdc2p34 phosphorylation is required for export of MdmX from the nucleus. Consequently, cells that express MdmX(S96A) retain Mdm2 in their nuclei, suggesting that export of Mdm2 to the cytoplasm is MdmX-dependent. Similarly, treatment of cells with the pharmacological inhibitor of CDK2/Cdc2p34 or with a dominant-negative Cdc2 results in nuclear localization of MdmX and Mdm2 and decreases the level of Mdm2 expression. Since Cdc2p34 is active in nonstressed conditions, our finding provides a novel insight into the signaling cascade involved in the regulation of MdmX localization and for regulation of Mdm2 localization and stability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735705     DOI: 10.1038/sj.onc.1208488

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.

Authors:  Yetao Jin; Mu-Shui Dai; Steven Z Lu; Yingda Xu; Zhijun Luo; Yingming Zhao; Hua Lu
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

2.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

3.  MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Authors:  Anna de Polo; Varunika Vivekanandan; John B Little; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

4.  Nucleolar localization and dynamic roles of flap endonuclease 1 in ribosomal DNA replication and damage repair.

Authors:  Zhigang Guo; Limin Qian; Ren Liu; Huifang Dai; Mian Zhou; Li Zheng; Binghui Shen
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

Review 5.  Functions of MDMX in the modulation of the p53-response.

Authors:  Kristiaan Lenos; Aart G Jochemsen
Journal:  J Biomed Biotechnol       Date:  2011-03-22

6.  A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability.

Authors:  Mengling Wang; Xueyi Zeng; Shengyou Li; Zekun Sun; Jia Yu; Chao Chen; Xiangchun Shen; Weidong Pan; Heng Luo
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

7.  MDM4 (MDMX) and its Transcript Variants.

Authors:  F Mancini; G Di Conza; F Moretti
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

8.  p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.

Authors:  Shin-Hyung Park; Myeong-A Seong; Ho-Young Lee
Journal:  Oncotarget       Date:  2016-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.